跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ALFUZOSIN PROLONGED RELEASE TABLET 10MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-ALFUZOSIN PROLONGED RELEASE TABLET 10MG
Approved
THERAPEUTIC
APO-ALFUZOSIN PROLONGED RELEASE TABLET 10MG
APOTEX INC (SIGNET) - CANADAAPOTEX INC (WESTON ROAD) (PRIMARY AND SECONDARY PACKAGER) (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 19, 2018
Approval ID
6c396e450a89f435
Company
APOTEX INC (SIGNET) - CANADAAPOTEX INC (WESTON ROAD) (PRIMARY AND SECONDARY PACKAGER) (CANADA)
Type
Therapeutic
Approval Details
Approval Id
6c396e450a89f435
Drug Name
APO-ALFUZOSIN PROLONGED RELEASE TABLET 10MG
Product Name
APO-ALFUZOSIN PROLONGED RELEASE TABLET 10MG
Approval Number
SIN15512P
Approval Date
2018-07-19
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
G04CA01
Atc Item Name
alfuzosin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
Alfuzosin Hydrochloride
10mg
Alfuzosin Hydrochloride
10mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 19, 2018
Approval ID
6c396e450a89f435
Type
Therapeutic
Back to HSA Approvals
